Genta Incorporated

Berkeley Heights, New Jersey 07922

0 studies enrolling now · 4 studies all time

What they study most

Leukemia, Melanoma (Skin), Multiple Myeloma and Plasma Cell Neoplasm

Studies at this site

• Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma — Completed
• Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia — Completed
• Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia — Completed